Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ADD. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106631991B details a safer, platinum-free synthesis route for hindered amine light stabilizer intermediates, offering significant cost and safety advantages.
Patent CN102976995B reveals a novel organocatalytic route for pyrrolysine. Achieve high enantioselectivity and cost reduction in amino acid manufacturing with scalable methods.
Patent CN110092753B reveals a high-yield 4-step synthesis for 3-azabicyclo[4.1.0]heptane-2-carboxylic acid, offering significant cost reduction and scalable supply chain solutions.
Advanced 5-step synthesis of FTY720 intermediate via patent CN1814583A. Offers significant cost reduction and high purity for immunosuppressant manufacturing.
Patent CN111763157B reveals a novel one-step asymmetric synthesis for chiral amino compounds, enabling cost reduction in pharmaceutical manufacturing and safer scale-up.
Discover a novel [3+3] cycloaddition route for chiral spiro-1,4-benzodiazepine-2-ones. Efficient synthesis with high stereoselectivity for pharmaceutical applications.
Novel Rh-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates with AURKA inhibitory activity and scalable production capabilities.
Patent CN107629020B reveals a metal-free synthesis route for 4H-1,2,4-oxadiazine-5(6H)-one derivatives, offering cost-effective manufacturing for agrochemical and pharmaceutical intermediates.
Patent CN109232586B reveals a metal carbene template method for synthesizing 3D polyimidazolium cages, offering high yields and scalable production for advanced material applications.
Patent CN111233795B reveals organic catalytic method. High yield and stereoselectivity ensure reliable supply chain for antitumor drug manufacturing.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Patent CN110872218B reveals a green Cu-catalyzed route for benzofluorenone synthesis. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN107325122B reveals a streamlined synthesis for prostaglandin intermediates, offering significant cost reduction and enhanced safety for pharmaceutical manufacturing.
Patent CN121342656A reveals copper-catalyzed BCN-OSu synthesis improving yield and purity. Enables cost reduction and reliable supply chain for bio-orthogonal reagents.
Novel iron-catalyzed synthesis offers high purity and cost efficiency for pharmaceutical intermediates supply chains globally ensuring reliable production and significant cost reduction.
Novel asymmetric dearomatization method for chiral benzofurans with high enantioselectivity. Offers cost-effective routes for pharmaceutical intermediates.
Patent CN115403494B enables air-oxidized, metal-free synthesis of beta-hydroxy sulfones. Delivers high purity, cost efficiency, and scalable supply for pharmaceutical intermediates.
Patent CN110256479B reveals a novel Ag/Cu-catalyzed route to chiral silicon pyrrolidines. Discover high-ee synthesis, mild conditions, and scalable manufacturing advantages.
Novel catalytic coupling method for high-purity 3 3' 4 4' tetraaminobiphenyl. Reduces cost and improves supply chain reliability for polymer manufacturers.
Novel chiral auxiliary method for Tapentadol intermediates. High purity, scalable process reducing costs and lead time for pharmaceutical manufacturing supply chains.